ROCKWELL MEDICAL, INC. Increase (Decrease) in Operating Capital
ROCKWELL MEDICAL, INC. (RMTI) reported Increase (Decrease) in Operating Capital of $1.61 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingCapital · last filed 2026-03-26
- ROCKWELL MEDICAL, INC. increase (decrease) in operating capital for the quarter ending 2023-06-30 was -$463.00K, a 125.97% decline year-over-year.
- ROCKWELL MEDICAL, INC. increase (decrease) in operating capital for the quarter ending 2023-03-31 was $3.06M, a 4.94% decline year-over-year.
- ROCKWELL MEDICAL, INC. increase (decrease) in operating capital for the quarter ending 2022-12-31 was -$985.00K, a 176.53% decline year-over-year.
- ROCKWELL MEDICAL, INC. increase (decrease) in operating capital for the quarter ending 2022-09-30 was -$1.89M, a 442.65% decline year-over-year.
- ROCKWELL MEDICAL, INC. increase (decrease) in operating capital for fiscal 2025 was $1.61M, a 5.63% increase from fiscal 2024.
- ROCKWELL MEDICAL, INC. increase (decrease) in operating capital for fiscal 2024 was $1.53M, a 78.92% decline from fiscal 2023.
- ROCKWELL MEDICAL, INC. increase (decrease) in operating capital for fiscal 2023 was $7.24M, a 240.73% increase from fiscal 2022.
- ROCKWELL MEDICAL, INC. increase (decrease) in operating capital for fiscal 2022 was $2.13M, a 56.10% decline from fiscal 2021.
| Period end | Increase (Decrease) in Operating Capital 3 month | Increase (Decrease) in Operating Capital 3 month as first filed | Increase (Decrease) in Operating Capital 6 month | Increase (Decrease) in Operating Capital 6 month as first filed | Increase (Decrease) in Operating Capital 9 month | Increase (Decrease) in Operating Capital 9 month as first filed | Increase (Decrease) in Operating Capital 12 month | Increase (Decrease) in Operating Capital 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $1.61M 10-K · filed 2026-03-26 | |||||||
| 2024-12-31 | $1.53M 10-K · filed 2026-03-26 | |||||||
| 2023-12-31 | $7.24M 10-K · filed 2025-03-20 | |||||||
| 2023-06-30 | -$463.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $2.59M 10-Q · filed 2023-08-14 | $1.61M derived: sum of 3 quarters · filed 2024-03-21 | -$279.00K derived: sum of 4 quarters · filed 2024-03-21 | ||||
| 2023-03-31 | $3.06M 10-Q · filed 2023-05-15 | $2.07M derived: sum of 2 quarters · filed 2024-03-21 | $184.00K derived: sum of 3 quarters · filed 2024-03-21 | $1.97M derived: sum of 4 quarters · filed 2024-03-21 | ||||
| 2022-12-31 | -$985.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$2.87M derived: sum of 2 quarters · filed 2024-03-21 | -$1.09M derived: sum of 3 quarters · filed 2024-03-21 | $2.13M 10-K · filed 2024-03-21 | $2.61M 10-K · filed 2023-03-30 | |||
| 2022-09-30 | -$1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$105.00K derived: sum of 2 quarters · filed 2023-08-14 | $3.11M 10-Q · filed 2022-11-14 | $4.40M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-06-30 | $1.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $5.00M 10-Q · filed 2023-08-14 | $6.29M derived: sum of 3 quarters · filed 2023-08-14 | $6.84M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $3.22M 10-Q · filed 2023-05-15 | $4.50M derived: sum of 2 quarters · filed 2023-05-15 | $5.05M derived: sum of 3 quarters · filed 2023-05-15 | $2.77M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.84M derived: sum of 2 quarters · filed 2023-03-30 | -$450.00K derived: sum of 3 quarters · filed 2023-03-30 | $4.84M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $551.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$1.74M derived: sum of 2 quarters · filed 2022-11-14 | $3.56M 10-Q · filed 2022-11-14 | $4.89M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$2.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $3.00M 10-Q · filed 2022-08-15 | $4.34M derived: sum of 3 quarters · filed 2022-08-15 | $3.09M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $5.29M 10-Q · filed 2022-05-16 | $6.63M derived: sum of 2 quarters · filed 2022-05-16 | $5.38M derived: sum of 3 quarters · filed 2022-05-16 | $8.14M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $85.00K derived: sum of 2 quarters · filed 2022-04-08 | $2.85M derived: sum of 3 quarters · filed 2022-04-08 | $2.96M 10-K · filed 2022-04-08 | ||||
| 2020-09-30 | -$1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.51M derived: sum of 2 quarters · filed 2021-11-15 | $1.62M 10-Q · filed 2021-11-15 | $1.32M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $2.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $2.87M 10-Q · filed 2021-08-16 | $2.87M 10-Q · filed 2020-08-10 | $2.57M derived: sum of 3 quarters · filed 2021-08-16 | $3.49M derived: sum of 4 quarters · filed 2021-08-16 | |||
| 2020-03-31 | $108.00K 10-Q · filed 2021-05-17 | $108.37K 10-Q · filed 2020-05-11 | -$197.00K derived: sum of 2 quarters · filed 2021-05-17 | $727.35K derived: sum of 3 quarters · filed 2021-05-17 | $3.16M derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | -$305.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $619.35K derived: sum of 2 quarters · filed 2021-03-31 | $3.05M derived: sum of 3 quarters · filed 2021-03-31 | $1.98M 10-K · filed 2021-03-31 | $1.98M 10-K · filed 2020-03-17 | |||
| 2019-09-30 | $924.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $3.36M derived: sum of 2 quarters · filed 2020-11-09 | $2.28M 10-Q · filed 2020-11-09 | $2.28M 10-Q · filed 2019-11-12 | $7.28M derived: sum of 4 quarters · filed 2020-11-09 | |||
| 2019-06-30 | $2.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $1.36M 10-Q · filed 2020-08-10 | $6.36M derived: sum of 3 quarters · filed 2020-08-10 | $4.57M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | -$1.07M 10-Q · filed 2020-05-11 | $3.92M derived: sum of 2 quarters · filed 2020-05-11 | $2.14M derived: sum of 3 quarters · filed 2020-05-11 | $674.67K derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $3.21M derived: sum of 2 quarters · filed 2020-03-17 | $1.75M derived: sum of 3 quarters · filed 2020-03-17 | $3.43M 10-K · filed 2020-03-17 | ||||
| 2018-09-30 | -$1.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$3.25M derived: sum of 2 quarters · filed 2019-11-12 | -$1.57M 10-Q · filed 2019-11-12 | -$4.43M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | -$1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $217.16K 10-Q · filed 2019-08-09 | -$2.65M derived: sum of 3 quarters · filed 2019-08-09 | -$1.41M derived: sum of 4 quarters · filed 2019-08-09 | ||||
| 2018-03-31 | $1.68M 10-Q · filed 2019-05-10 | $683.05K 10-Q · filed 2018-05-10 | -$1.18M derived: sum of 2 quarters · filed 2019-05-10 | $54.10K derived: sum of 3 quarters · filed 2019-05-10 | $2.64M derived: sum of 4 quarters · filed 2019-05-10 | |||
| 2017-12-31 | -$2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$1.63M derived: sum of 2 quarters · filed 2019-03-18 | $957.06K derived: sum of 3 quarters · filed 2019-03-18 | $3.68M 10-K · filed 2019-03-18 | ||||
| 2017-09-30 | $1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $3.82M derived: sum of 2 quarters · filed 2018-11-09 | $6.55M 10-Q · filed 2018-11-09 | $3.69M derived: sum of 4 quarters · filed 2018-11-09 | ||||
| 2017-06-30 | $2.59M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-14 | $5.31M 10-Q · filed 2018-08-14 | $5.45M 10-Q · filed 2017-08-09 | $2.45M derived: sum of 3 quarters · filed 2018-08-14 | $7.38M derived: sum of 4 quarters · filed 2018-08-14 | |||
| 2017-03-31 | $2.73M 10-Q/A · filed 2018-08-14 | $2.82M 10-Q · filed 2017-05-09 | -$132.96K derived: sum of 2 quarters · filed 2018-08-14 | $4.80M derived: sum of 3 quarters · filed 2018-08-14 | $7.40M derived: sum of 4 quarters · filed 2018-08-14 | |||
| 2016-12-31 | -$2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $2.07M derived: sum of 2 quarters · filed 2018-03-15 | $4.67M derived: sum of 3 quarters · filed 2018-03-15 | $3.79M 10-K · filed 2018-03-15 | ||||
| 2016-09-30 | $4.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $7.53M derived: sum of 2 quarters · filed 2017-11-08 | $6.65M 10-Q · filed 2017-11-08 | $6.59M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2016-06-30 | $2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $1.73M 10-Q · filed 2017-08-09 | $1.66M derived: sum of 3 quarters · filed 2018-03-15 | $4.45M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2016-03-31 | -$878.64K 10-Q · filed 2017-05-09 | -$941.35K derived: sum of 2 quarters · filed 2018-03-15 | $1.84M derived: sum of 3 quarters · filed 2018-03-15 | $6.15M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2015-12-31 | -$62.70K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $2.72M derived: sum of 2 quarters · filed 2018-03-15 | $7.03M derived: sum of 3 quarters · filed 2018-03-15 | $8.68M 10-K · filed 2018-03-15 | ||||
| 2015-09-30 | $2.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $7.09M derived: sum of 2 quarters · filed 2016-11-07 | $8.74M 10-Q · filed 2016-11-07 | -$10.12M derived: sum of 4 quarters · filed 2017-03-15 | ||||
| 2015-06-30 | $4.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $5.96M 10-Q · filed 2016-08-09 | -$12.90M derived: sum of 3 quarters · filed 2017-03-15 | -$14.78M derived: sum of 4 quarters · filed 2017-03-15 | ||||
| 2015-03-31 | $1.65M 10-Q · filed 2016-05-10 | -$17.21M derived: sum of 2 quarters · filed 2017-03-15 | -$19.08M derived: sum of 3 quarters · filed 2017-03-15 | -$16.29M derived: sum of 4 quarters · filed 2017-03-15 | ||||
| 2014-12-31 | -$18.86M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$20.73M derived: sum of 2 quarters · filed 2017-03-15 | -$17.95M derived: sum of 3 quarters · filed 2017-03-15 | -$12.73M 10-K · filed 2017-03-15 | ||||
| 2014-09-30 | -$1.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $912.74K derived: sum of 2 quarters · filed 2015-11-09 | $6.13M 10-Q · filed 2015-11-09 | $8.05M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $8.01M 10-Q · filed 2015-08-04 | $9.93M derived: sum of 3 quarters · filed 2016-02-29 | $9.00M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $5.22M 10-Q · filed 2015-05-07 | $7.14M derived: sum of 2 quarters · filed 2016-02-29 | $6.21M derived: sum of 3 quarters · filed 2016-02-29 | $17.79M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $990.80K derived: sum of 2 quarters · filed 2016-02-29 | $12.57M derived: sum of 3 quarters · filed 2016-02-29 | $11.07M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | -$928.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $10.65M derived: sum of 2 quarters · filed 2014-11-10 | $9.15M 10-Q · filed 2014-11-10 | $5.23M derived: sum of 4 quarters · filed 2015-03-03 | ||||
| 2013-06-30 | $11.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $10.08M 10-Q · filed 2014-07-31 | $6.16M derived: sum of 3 quarters · filed 2015-03-03 | -$623.18K derived: sum of 4 quarters · filed 2015-03-03 | ||||
| 2013-03-31 | -$1.50M 10-Q · filed 2014-05-12 | -$5.42M derived: sum of 2 quarters · filed 2015-03-03 | -$12.20M derived: sum of 3 quarters · filed 2015-03-03 | -$15.81M derived: sum of 4 quarters · filed 2015-03-03 | ||||
| 2012-12-31 | -$3.92M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | -$10.70M derived: sum of 2 quarters · filed 2015-03-03 | -$14.31M derived: sum of 3 quarters · filed 2015-03-03 | -$14.80M 10-K · filed 2015-03-03 | ||||
| 2012-09-30 | -$6.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | -$10.39M derived: sum of 2 quarters · filed 2013-11-05 | -$10.88M 10-Q · filed 2013-11-05 | -$14.72M derived: sum of 4 quarters · filed 2014-03-07 | ||||
| 2012-06-30 | -$3.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$4.10M 10-Q · filed 2013-08-01 | -$7.93M derived: sum of 3 quarters · filed 2014-03-07 | -$9.48M derived: sum of 4 quarters · filed 2014-03-07 | ||||
| 2012-03-31 | -$488.06K 10-Q · filed 2013-05-08 | -$4.32M derived: sum of 2 quarters · filed 2014-03-07 | -$5.87M derived: sum of 3 quarters · filed 2014-03-07 | -$8.52M derived: sum of 4 quarters · filed 2014-03-07 | ||||
| 2011-12-31 | -$3.84M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$5.38M derived: sum of 2 quarters · filed 2014-03-07 | -$8.04M derived: sum of 3 quarters · filed 2014-03-07 | -$4.99M 10-K · filed 2014-03-07 | ||||
| 2011-09-30 | -$1.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$4.20M derived: sum of 2 quarters · filed 2012-11-09 | -$1.16M 10-Q · filed 2012-11-09 | -$2.26M derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-06-30 | -$2.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $386.41K 10-Q · filed 2012-08-07 | -$719.67K derived: sum of 3 quarters · filed 2013-03-18 | $439.78K derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-03-31 | $3.04M 10-Q · filed 2012-05-07 | $1.94M derived: sum of 2 quarters · filed 2013-03-18 | $3.10M derived: sum of 3 quarters · filed 2013-03-18 | |||||
| 2010-12-31 | -$1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $53.38K derived: sum of 2 quarters · filed 2013-03-18 | $645.96K 10-K · filed 2013-03-18 | |||||
| 2010-09-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $1.75M 10-Q · filed 2011-11-04 | ||||||
| 2010-06-30 | $592.59K 10-Q · filed 2011-08-05 | |||||||
| 2009-12-31 | -$451.47K 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |